Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 27 | $12,897,789 |
Sells | 229 | $30,354,201 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
28 Apr 2023 16:32 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Jan 2022 | Sale A | 18,500 | 7.3875 | 136,669 | D |
08 Jul 2022 18:36 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 07 Jul 2022 | Sale | 1,000 | 9.0678 | 9,068 | I |
08 Jul 2022 18:36 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 07 Jul 2022 | Sale | 1,000 | 9.07 | 9,070 | I |
08 Jul 2022 18:36 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 07 Jul 2022 | Sale | 500 | 9.0621 | 4,531 | I |
08 Jul 2022 18:36 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 07 Jul 2022 | Sale | 18,500 | 9.0673 | 167,745 | D |
08 Jul 2022 18:36 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 07 Jul 2022 | Sale | 18,614 | 9.038 | 168,233 | D |
05 Aug 2022 19:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Aug 2022 | Sale | 1,000 | 9.447 | 9,447 | I |
05 Aug 2022 19:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Aug 2022 | Sale | 1,000 | 9.4477 | 9,448 | I |
05 Aug 2022 19:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Aug 2022 | Sale | 500 | 9.4442 | 4,722 | I |
05 Aug 2022 19:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Aug 2022 | Sale | 18,500 | 9.4529 | 174,879 | D |
05 Aug 2022 19:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Aug 2022 | Sale | 18,325 | 9.5259 | 174,562 | D |
17 Aug 2022 18:34 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 16 Aug 2022 | Sale | 16,000 | 12.6023 | 201,637 | D |
17 Aug 2022 18:35 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 16 Aug 2022 | Sale | 30,000 | 12.6148 | 378,444 | D |
02 Sep 2022 19:24 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Sep 2022 | Sale | 1,000 | 10.5044 | 10,504 | I |
02 Sep 2022 19:24 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Sep 2022 | Sale | 1,000 | 10.5021 | 10,502 | I |
02 Sep 2022 19:24 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Sep 2022 | Sale | 500 | 10.4975 | 5,249 | I |
02 Sep 2022 19:24 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Sep 2022 | Sale | 18,500 | 10.4887 | 194,041 | D |
02 Sep 2022 19:24 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Sep 2022 | Sale | 18,066 | 10.1795 | 183,903 | D |
16 Sep 2022 18:58 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Sep 2022 | Sale | 400 | 13.9725 | 5,589 | D |
16 Sep 2022 18:58 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Sep 2022 | Sale | 9,600 | 13.3381 | 128,046 | D |
03 Oct 2022 19:32 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 29 Sep 2022 | Sale | 64 | 11.53 | 738 | D |
03 Oct 2022 19:32 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 29 Sep 2022 | Sale | 15,936 | 10.8566 | 173,011 | D |
07 Oct 2022 19:19 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Oct 2022 | Sale | 1,000 | 11.6414 | 11,641 | I |
07 Oct 2022 19:19 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Oct 2022 | Sale | 1,000 | 11.6428 | 11,643 | I |
07 Oct 2022 19:19 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Oct 2022 | Sale | 500 | 11.6421 | 5,821 | I |
07 Oct 2022 19:19 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Oct 2022 | Sale | 18,500 | 11.6514 | 215,551 | D |
07 Oct 2022 19:19 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Oct 2022 | Sale | 17,553 | 11.5033 | 201,917 | D |
18 Oct 2022 17:08 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 14 Oct 2022 | Sale | 5,000 | 10.6259 | 53,130 | D |
18 Oct 2022 17:08 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 14 Oct 2022 | Sale | 5,000 | 11.21 | 56,050 | D |
28 Oct 2022 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 27 Oct 2022 | Sale | 16,000 | 10.7156 | 171,450 | D |
04 Nov 2022 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Nov 2022 | Sale | 1,000 | 10.0993 | 10,099 | I |
04 Nov 2022 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Nov 2022 | Sale | 1,000 | 10.0984 | 10,098 | I |
04 Nov 2022 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Nov 2022 | Sale | 500 | 10.1104 | 5,055 | I |
04 Nov 2022 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Nov 2022 | Sale | 18,500 | 10.1101 | 187,037 | D |
04 Nov 2022 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Nov 2022 | Sale | 18,193 | 9.889 | 179,911 | D |
17 Nov 2022 18:47 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Nov 2022 | Sale | 4,941 | 11.9153 | 58,873 | D |
17 Nov 2022 18:47 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Nov 2022 | Sale | 5,059 | 12.7 | 64,249 | D |
18 Nov 2022 17:47 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 16 Nov 2022 | Sale | 17,770 | 11.1204 | 197,610 | D |
17 Nov 2022 18:46 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 17 Nov 2022 | Sale | 16,000 | 10.9626 | 175,402 | D |
01 Dec 2022 17:14 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 29 Nov 2022 | Sale | 8,885 | 8.7547 | 77,786 | D |
02 Dec 2022 18:17 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Dec 2022 | Sale | 1,000 | 9.2773 | 9,277 | I |
02 Dec 2022 18:17 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Dec 2022 | Sale | 1,000 | 9.2773 | 9,277 | I |
02 Dec 2022 18:17 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Dec 2022 | Sale | 500 | 9.2648 | 4,632 | I |
02 Dec 2022 18:17 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Dec 2022 | Sale | 18,500 | 9.2765 | 171,615 | D |
02 Dec 2022 18:17 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Dec 2022 | Sale | 18,710 | 8.7731 | 164,145 | D |
15 Dec 2022 17:26 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 13 Dec 2022 | Sale | 8,885 | 8.9587 | 79,598 | D |
19 Dec 2022 17:32 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Dec 2022 | Sale | 10,000 | 8.8525 | 88,525 | D |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 23 Dec 2022 | Purchase | 100,378 | 7.5158 | 754,421 | I |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 27 Dec 2022 | Purchase | 145,652 | 7.2392 | 1,054,404 | I |
29 Dec 2022 17:39 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 27 Dec 2022 | Sale | 8,885 | 7.2451 | 64,373 | D |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 28 Dec 2022 | Purchase | 71,299 | 7.1796 | 511,898 | I |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 29 Dec 2022 | Purchase | 84,622 | 7.714 | 652,774 | I |
30 Dec 2022 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 29 Dec 2022 | Sale | 8,000 | 7.6958 | 61,566 | D |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 30 Dec 2022 | Purchase | 99,754 | 7.5548 | 753,622 | I |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 03 Jan 2023 | Purchase | 141,646 | 7.5047 | 1,063,011 | I |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 04 Jan 2023 | Purchase | 91,892 | 7.8013 | 716,877 | I |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 05 Jan 2023 | Purchase | 80,035 | 7.3787 | 590,554 | I |
06 Jan 2023 18:28 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Jan 2023 | Sale | 1,000 | 7.3822 | 7,382 | I |
06 Jan 2023 18:28 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Jan 2023 | Sale | 1,000 | 7.3907 | 7,391 | I |
06 Jan 2023 18:28 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Jan 2023 | Sale | 500 | 7.3789 | 3,689 | I |
06 Jan 2023 18:28 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Jan 2023 | Sale | 18,500 | 7.3875 | 136,669 | D |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 06 Jan 2023 | Purchase | 68,953 | 7.4052 | 510,611 | I |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 09 Jan 2023 | Purchase | 76,046 | 7.638 | 580,839 | I |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 10 Jan 2023 | Purchase | 69,518 | 7.7224 | 536,846 | I |
12 Jan 2023 17:46 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 10 Jan 2023 | Sale | 8,885 | 7.6852 | 68,283 | D |
19 Jan 2023 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 17 Jan 2023 | Sale | 10,000 | 9.1561 | 91,561 | D |
26 Jan 2023 18:04 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 24 Jan 2023 | Sale | 8,885 | 8.7077 | 77,368 | D |
26 Jan 2023 16:11 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 25 Jan 2023 | Purchase | 24,526 | 7.8801 | 193,267 | I |
27 Jan 2023 17:03 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 26 Jan 2023 | Sale | 8,000 | 8.0684 | 64,547 | D |
27 Jan 2023 16:27 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 26 Jan 2023 | Purchase | 7,886 | 7.9896 | 63,006 | I |
02 Feb 2023 16:07 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 01 Feb 2023 | Purchase | 600 | 7.97 | 4,782 | I |
03 Feb 2023 17:11 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Feb 2023 | Sale | 1,000 | 9.2017 | 9,202 | I |
03 Feb 2023 17:11 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Feb 2023 | Sale | 1,000 | 9.2075 | 9,208 | I |
03 Feb 2023 17:11 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Feb 2023 | Sale | 500 | 9.2082 | 4,604 | I |
03 Feb 2023 17:11 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Feb 2023 | Sale | 18,500 | 9.2188 | 170,548 | D |
09 Feb 2023 16:53 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 07 Feb 2023 | Sale | 8,885 | 8.8084 | 78,263 | D |
13 Feb 2023 16:41 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 10 Feb 2023 | Purchase | 11,000 | 7.9825 | 87,808 | I |
14 Feb 2023 16:10 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 13 Feb 2023 | Purchase | 32,474 | 7.9706 | 258,837 | I |
15 Feb 2023 16:06 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 14 Feb 2023 | Purchase | 6,300 | 7.946 | 50,060 | I |
17 Feb 2023 17:13 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Feb 2023 | Sale | 7,486 | 8.33 | 62,358 | D |
17 Feb 2023 17:27 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 16 Feb 2023 | Purchase | 42,682 | 7.8966 | 337,043 | I |
17 Feb 2023 17:13 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 16 Feb 2023 | Sale | 1,768 | 8.42 | 14,887 | D |
21 Feb 2023 16:07 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 17 Feb 2023 | Purchase | 63,382 | 7.7149 | 488,986 | I |
23 Feb 2023 17:48 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 21 Feb 2023 | Sale | 8,885 | 7.733 | 68,708 | D |
22 Feb 2023 16:07 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 21 Feb 2023 | Purchase | 94,418 | 7.7435 | 731,126 | I |
23 Feb 2023 16:26 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 22 Feb 2023 | Purchase | 50,941 | 7.8329 | 399,016 | I |
27 Feb 2023 17:46 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 23 Feb 2023 | Sale | 8,000 | 7.8175 | 62,540 | D |
24 Feb 2023 16:08 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 23 Feb 2023 | Purchase | 51,864 | 7.7856 | 403,792 | I |
27 Feb 2023 16:06 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 24 Feb 2023 | Purchase | 109,118 | 7.639 | 833,552 | I |
28 Feb 2023 16:14 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 27 Feb 2023 | Purchase | 52,500 | 7.69 | 403,725 | I |
01 Mar 2023 16:06 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 28 Feb 2023 | Purchase | 815 | 7.97 | 6,496 | I |
02 Mar 2023 16:05 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 01 Mar 2023 | Purchase | 48,867 | 7.9416 | 388,082 | I |
06 Mar 2023 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Mar 2023 | Sale | 1,000 | 7.9086 | 7,909 | I |
06 Mar 2023 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Mar 2023 | Sale | 1,000 | 7.9059 | 7,906 | I |
06 Mar 2023 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Mar 2023 | Sale | 500 | 7.9041 | 3,952 | I |
06 Mar 2023 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Mar 2023 | Sale | 18,500 | 7.919 | 146,502 | D |
03 Mar 2023 16:09 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 02 Mar 2023 | Purchase | 66,822 | 7.8171 | 522,354 | I |
09 Mar 2023 17:36 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 07 Mar 2023 | Sale | 8,885 | 8.3274 | 73,989 | D |
10 Mar 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 08 Mar 2023 | Sale | 1,000 | 8.0867 | 8,087 | I |
10 Mar 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 08 Mar 2023 | Sale | 20,000 | 8.095 | 161,900 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)